Bayer’s heritage in pharmaceuticals goes back almost 125 years, with the first therapy manufactured in 1888. Bayer quickly developed a reputation, particularly in treating infectious diseases. Gerhard Domagk, a Bayer researcher, who discovered the antibacterial effect of sulfonamides was awarded the Nobel Prize in Medicine in 1939.
We concentrate on five big therapeutic groups in which we make essential contributions to medical progress:
- Cardiovascular and blood diseases
- Oncological diseases
- Women's healthcare
- Imaging techniques